LY 235959
Chemical Name: [3S-(3α,4aα,6β,8aα)]-Decahydro-6-(phosphonomethyl)-3-isoquinolinecarboxylic acid)
Biological Activity
LY 235959 is a competitive NMDA receptor antagonist.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Additional Information
Background References
-
Competitive and non-competitive NMDA antagonists induce similar limbic degeneration.
Ellison
Neuroreport, 1994;5:2688 -
Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice.
Borowicz et al.
Epilepsia, 1996;37:618
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for LY 235959
The citations listed below are publications that use Tocris products. Selected citations for LY 235959 include:
2 Citations: Showing 1 - 2
-
Habenular α5 nicotinic receptor subunit signalling controls nicotine intake.
Authors: Fowler Et al.
Nature 2011;471:597
-
NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala.
Authors: Kenny Et al.
Neuropsychopharmacology 2009;34:266
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for LY 235959
There are currently no reviews for this product. Be the first to review LY 235959 and earn rewards!
Have you used LY 235959?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
